Skip to content

Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)

Timing of Smoking Intervention in Alcohol Treatment

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000444
Enrollment
500
Registered
1999-11-03
Start date
1997-09-30
Completion date
2004-01-31
Last updated
2011-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism, Smoking

Brief summary

This study will attempt to determine the best time to begin a smoking cessation program in individuals who undergo intensive treatment for alcohol dependence. The goal of this trial is to determine whether a smoking cessation program is more effective if it occurs at the same time as or after treatment for alcohol dependence. The study also will attempt to determine the effect of smoking cessation programs on the outcome of treatment for alcohol dependence.

Interventions

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Minneapolis Veterans Affairs Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Meets criteria for alcohol use disorder and other drug dependence. * Complete first week of alcohol treatment program. * Current cigarette smoker (more than 5 cigarettes/day, smoking more than 1 year).

Exclusion criteria

* Lifetime diagnosis of an excluding psychiatric disorder: bipolar disorder, schizophrenia or other psychotic disorder, panic disorder with or without agoraphobia, obsessive-compulsive disorder, generalized anxiety disorder, eating disorder, post- traumatic stress disorder, antisocial personality disorder, or borderline personality disorder. * Unable to participate in protocol due to functional deficits or severe depression. * Suicidal or homicidal ideation. * Current use of disulfiram (Antabuse) or naltrexone (Revia). * Current use of pipes, cigars, or smokeless tobacco and unwillingness to stop. * Lives more than 100 miles from alcohol treatment facility. * No telephone.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026